D-Wave Quantum receives a Sell rating due to lagging technology, negligible revenues, and an excessive forward P/S multiple.

Accurately measuring small shifts in biological markers, like proteins and neurotransmitters, or harmful chemicals in the water supply, can identify critical problems before they have a chance to ...

The research team led by Researcher Tianyu Wang from the School of Integrated Circuits at Shandong University has systematically reviewed the latest advances in emerging memristors for in-memory ...

The 2026 Gate River Run set a national record with 15,385 finishers in the 15K race, making it the largest 15K competition in ...

When considering the drugs most likely to cause former addicts to repeatedly relapse, opioids, cocaine, and methamphetamine ...

Drug addiction carries an extremely high risk of relapse, as cravings can be reignited by minor stimuli even long after one ...

An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed ...

And those heading to the track will have more choice than ever to make the most of petrol head heaven, with organisers ...

D-Wave Quantum (NYSE:QBTS) and IonQ (NYSE:IONQ | IONQ Price Prediction) both just reported earnings, revealing two very ...

Researchers developed compilation-based quantum process tomography, a framework that reconstructs quantum operations using fewer measurements than conventional methods.